P Pu ur rp po os se e: : To describe the outbreak of severe acute respiratory syndrome (SARS) in Toronto, its impact on anesthesia practice and the infection control guidelines adopted to manage patients in the operating room (OR) and to provide emergency intubation outside the OR.
Objectif : Décrire l'éclosion du syndrome respiratoire aigu sévère (SRAS) à Toronto, son impact sur l'exercice de l'anesthésie et l'adoption de directives pour la prévention des infections pendant la prise en charge des patients en salle d'opération (SO) et l'intubation d'urgence à l'extérieur de la SO.

Éléments cliniques : L'éclosion du SRAS à Toronto a été le résultat d'un seul cas indicateur. Le virus en cause, CoV-SRAS, est modérément contagieux et se propage par contact et gouttelettes de salive. Il accède à son hôte par la muqueuse du tractus respiratoire et par les yeux. Il peut affecter autant les gens sains que les patients malades. Nous discutons de certaines mesures préventives comme le port de lunettes, de gants, de blouses et de masques et de l'application de diverses stratégies de lutte anti-infectieuse mises au point pour réduire la propagation du virus.
Conclusion : La vigilance et le contrôle strict de l'infection sont importants pour la prévention de la propagation du SRAS. La situation nous a fait redécouvrir les normes de lutte anti-infectieuse adaptées à l'exercice quotidien de l'anesthésie.
S of July 10, 2003 , 438 cases (250 probable, 188 suspect) of severe acute respiratory syndrome (SARS) were reported in Canada, 375 (85.3%) of which occurred in Ontario. 1 The majority of cases in Ontario occurred in the Greater Toronto Area (GTA). SARS has resulted in unprecedented apprehension in the local community and severe economic harm to local business and tourism. More importantly, it has challenged health care workers to use effective infection control measures. In the present article, we will discuss the infection control guidelines for the anesthesiologist that were adopted by our institution, the rationale behind them and the impact of the SARS outbreak on anesthesiologists in Toronto.
O Ou ut tb br re ea ak k i in n T To or ro on nt to o Since the outbreak of an atypical pneumonia in Guangdong Province of the People's Republic of China in late 2002, 2 similar cases were detected in surrounding areas such as Hong Kong and Vietnam. The illness was called Severe Acute Respiratory Syndrome (SARS) with a case definition (Table I ) from the World Health Organization (WHO). 3 On March 12, 2003 , WHO issued a global alert in relation to clusters of SARS. 4 In Toronto, the first documented case was a 78-yr-old woman who had travelled to Hong Kong on February 13 with her husband. 5 In Hong Kong, she and her husband stayed at a hotel at the same time and on the same floor as the Guangdong physician from whom the outbreak in Hong Kong originated. On returning to Toronto on February 23, she stayed in her apartment, which she shared with family members. Two days later, she became ill and died at home on March 5, 2003 . Several of the family subsequently developed respiratory symptoms. The 43-yr-old son was admitted to the emergency department of a community hospital in Scarborough that became the epicentre of the Toronto outbreak. By the end of April, 262 SARS cases (143 probable, 119 suspected) and 21 deaths had been reported in Ontario, the majority in the GTA. 6 All these cases could be traced back to the original index patient. On April 23, WHO issued a travel advisory warning for Toronto, which was removed one week later. On May 14, Toronto was removed from the list of areas affected by SARS as no new probable case had been reported since April 19. However, another cluster of SARS patients was discovered on May 23, 2003 . 7 The second cluster was traced to a 96-yr-old man who underwent surgery for a fractured pelvis in a hospital in North York on April 19. While in hospital he developed SARS but it was managed as postoperative pneumonia. He infected several other patients in his ward, including a woman who was later transferred to a rehabilitation hospital. This resulted in a further 118 cases in the GTA as of July 10, 2003.
1 Eventually, on July 2, WHO removed Toronto from the list of areas with recent local transmissions.
R Re e--e ex xa am mi in na at ti io on n o of f i in nf fe ec ct ti io on n c co on nt tr ro ol l m me ea as su ur re es s The SARS outbreak is unique in recent history of public health because of its rapidity of transmission, its concentration in health care settings and the large number of health care workers who were infected. In an analysis of a cohort of 144 patients with SARS in the GTA, 73 (51%) were health care workers, 8 including 14 (19%) physicians and 29 (40%) nurses. Anesthesiologists, as specialists in airway management, are at high risk because of frequent exposure to patients' respiratory secretions. Three anesthesiologists in our area were infected. 9 They contracted the disease after tracheal intubation of patients with respi- A with a history of: -high fever (> 38°C) AND -cough or breathing difficulty AND one or more of the following exposures during the ten days prior to onset of symptoms:
-close contact B with a person who is a suspect or probable case of severe acute respiratory syndrome (SARS); -history of travel to an area with recent local transmission of SARS -residing in an area with recent local transmission of SARS 2 A person with an unexplained acute respiratory illness resulting in death after 1 November 2002, A but on whom no autopsy has been performed AND one or more of the following exposures during to ten days prior to onset of symptoms:
-close contact, B with a person who is a suspect or probable case of SARS; -history of travel to an area with recent local transmission of SARS -residing in an area with recent local transmission of SARS Probable case 1 A suspect case with radiographic evidence of infiltrates consistent with pneumonia or respiratory distress syndrome (RDS) on chest x-ray (CXR). 2 A suspect case of SARS that is positive for SARS coronavirus by one or more assays. ratory failure of unknown cause. These cases occurred in the early stage of the outbreak before SARS was suspected. The anesthesiologists wore surgical facemasks, gowns and gloves but no goggles/visors.
International investigations have revealed important information that prompted health care workers to reexamine the precautionary measures for infection control.
SARS survival outside the body
The agent that causes SARS is a new coronavirus (SARS-CoV), unlike any other human or animal virus in the Coronavirus family. 10, 11 The virus can survive for up to 48 hr after drying on plastic surfaces. 12 In Hong Kong the virus survived in urine and feces for at least 24 and 48 hr respectively. In patients with diarrhea, the virus can survive up to four days in the stool sample which has a lower acidity than normal stools. 12 Thus, once the body is exposed to this viral agent, the body surface can be contaminated for an extended time. Similarly, exposed inanimate objects may act as carriers for up to 48 hr.
Transmission
The virus is spread predominately by infectious droplets and contact. Because of early reports of clusters of cases in community settings such as apartment buildings and the high infection rates among health care workers in Hong Kong, Taiwan, Hanoi and Toronto, the etiological agent of SARS was thought to be highly contagious. 13, 14 However, with the exception of 'superspreaders', there is growing evidence that SARSCoV is only moderately transmissible. 15, 16 The average number of secondary infections generated per case at the start of the epidemic was estimated as 2.7, which is much lower than that for influenza. 17 In some instances, however, a single individual ("superspreader") has directly infected a large number of other people. This is exemplified by the Singapore outbreak in which half of the first reported 201 probable cases were infected by five source cases. 18 Despite the discovery of the virus and its genome, it is still uncertain when patients are most infectious and how to identify 'superspreaders'. 19 
Mortality and morbidity
In Hong Kong and Toronto, most of the patients infected with SARS had no co-morbid illnesses and half of them (44-51%) were fit health care workers. 8, 20 Approximately one in five (20-23%) patients with SARS required admission to intensive care units (ICU) with or without ventilatory support.
In a detailed analysis of cases identified in the initial outbreak associated with the nosocomial transmission of SARS in the index hospital in Toronto, the case fatality rates were 2.9% and 53.8% for those aged less than or over 60 yr respectively. 1 The case-fatality rate was calculated by dividing the cumulative number of deaths within 60 days after symptom onset by the total number of probable and suspect cases. Data from the WHO 21 revealed that the overall case fatality ratio was 14 to 15% and was influenced by age (Table II) . This ratio was estimated by survival analysis based on the individual data from the onset of the illness until death or full recovery.
Barrier precautions
Early in the Toronto SARS outbreak, full protective gear (goggles, gowns, N95 masks and gloves) was considered to be sufficient to protect health care workers from SARS. In April, a number of health care workers contracted the infection during their care of SARS patients despite increased protective precautions. 22, 23 Experience from Hong Kong suggested that the infection among 'protected' health care worker was related to how well the precautionary measures were used. In a case-control survey, 24 they found no infection in staff using complete precautionary measures, whereas infected staff had omitted at least one of the precautionary measures. This demonstrates how difficult it is to practice and perfect full infection control in view of the long survival ability of the virus outside the body. Additional measures have been suggested. However, most important of all is the 'hypervigilance' of health care workers in practicing infection control measure.
I In nf fe ec ct ti io on n c co on nt tr ro ol l g gu ui id de el li in ne es s f fo or r a an ne es st th he es si ia a Exposure to oral and respiratory secretions at the time of tracheal intubation subjects the anesthesiologist to a serious risk of acquiring the infection. Health organizations and agencies such as WHO, 25 A A. . R Ro ou ut ti in ne e p pr re ec ca au ut ti io on ns s f fo or r n no on n--S SA AR RS S p pa at ti ie en nt ts s i in n t th he e O OR R ( (A Ap pp pe en nd di ix x I I) ) This guideline applies to all surgical patients and is based on long-standing recommendations by Health Canada that masks and eye protection or face shields should be worn where appropriate to protect the mucous membranes of the eyes, nose and mouth during procedures and patient care activities likely to generate splashes or sprays of blood, body fluids, secretions or excretions.
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For practical purposes, the anesthetic machine is considered 'dirty' and the anesthetic drug cart as 'clean'. The machine is usually the first area anesthesiologists touch after contact with the patient. A large container is positioned on the anesthesia machine in which all airway equipment (laryngoscope blade and handle, mask, suction catheter, etc.) is placed after use. The container and its contents are removed from the OR as soon as possible following intubation. The contents are separated for cleaning, sterilization or disposal before they are returned to the OR. A second set of equipment including clean masks, laryngoscope handles and blades is immediately available. All steps are taken to keep the anesthesia drug cart 'clean'. The cart is used only after hand-washing or removal of the outer pair of gloves. B B. . G Gu ui id de el li in ne es s f fo or r m ma an na ag ge em me en nt t o of f S SA AR RS S p pa at ti ie en nt ts s
Management of SARS patients in the OR (Appendix II)
Management of SARS patients requires conscientious efforts in infection control and careful planning. Transfer of a patient to the OR potentially exposes an innocent by-stander en route to the infective agent.
Thus, the infection control team should be informed about the transfer route. The spread of respiratory droplets from the infected patient should be minimized by the patient wearing a N95 mask without an expiratory valve. Staff involved in the transfer and the care of patients in the OR should take full droplet/contact precautions. Clean surgical scrub suits laundered by the hospital should be worn and personalized hats or hair covers are avoided. The rationale for using alcohol-based hand rub, N95 masks, gowns, gloves and powered respirators in the OR has been reviewed recently. 9 Because the SARS-CoV virus is spread by droplets and can survive on inanimate objects for 48 hr, extra precautions and vigilance are important to avoid contaminating anesthesia equipment or surfaces such as the telephone in the OR. Double gloves are recommended when handling SARS patients. The outer pair is removed after direct patient contact and before touching equipment or furniture in other areas of the room.
Of the precautions recommended above, the use of personal protection systems (PPS) may be the most unfamiliar for anesthesiologists. Although it is not currently recommended by Health Canada, 27 hospitals in Ontario are using PPS according to the directive from the Ministry of Health and Long-Term Care of Ontario to all Ontario Acute Care Hospitals for high-risk procedures. 28 The PPS adopted in our institution is the powered air-purifying respirator (PAPR 3M, Berkshire, UK) system while other hospitals have purchased the Stryker® T4 (Stryker, Kalamazoo, MI, USA) PPS. No consensus has been reached regarding which has the better air filtration system. Nonetheless, these systems are considered to be important barriers to protect health care workers during high-risk procedures such as intubation and extubation. The PAPR consists of a beltmounted powered air purifier with a high efficiency particulate air (HEPA) filter, connected via a tube to a lightweight headpiece (Figures 1 and 2) . The HEPA filter removes particles of 0.3 to 15 µ with an efficiency of 98 to 100%. 30 The lightweight hood or headpiece provides excellent coverage of the head, face and neck. We have several years experience in using the PAPR system in the bronchoscopy suite without disease transmission to health-care workers. There are several important clinical points to remember. First, it takes time, training and assistance to put on the personal protective equipment and the PAPR system properly. Advance warning of a patient in need of tracheal intubation is required in order to prepare properly. Second, the personal protective equipment must be removed in proper sequence to avoid contamination of the users. Third, it is difficult to communicate with each other due to the noise generat-ed by the high flow through the PAPR system. This noisy environment may cause errors due to its potential for miscommunication.
Contaminated protective gear must be removed before transferring the patient to the recovery room. Time should be allowed for the anesthesiologist and assistant to remove contaminated gloves, gowns, face shields or masks and head cover and renew protective precautions at the end of the case.
The anesthesia machine is protected with high efficiency, low volume filters placed in both the inspiratory and expiratory limbs of the circuit. Hydrophobic filters are used in our institution as the filtering process is based on pore size and not on hydrostatic charge. The hygroscopic filter based on hydrostatic charge may become overwhelmed when wet and will allow passage of virus. With the filter placed in both limbs of the circuit, the soda lime does not need to be changed but the end-tidal CO 2 sample line and trap must be changed after the case.
Most ORs currently use positive pressure with up to 20 room air exchanges per hour. Because of the high air exchanges in the OR, aerosolized infectious particles will be cleared rapidly. However, those in close contact during a high-risk procedure such as tracheal intubation/extubation may still have a high exposure, and those outside the room may be exposed to infectious aerosols if the door to the OR is left open. Therefore, movement in and out of the OR must be kept to a minimum during the procedure.
Local experience from personnel who contracted SARS during airway instrumentation suggested that patient coughing should be kept at a minimum before, during and after intubation and/or induction of anesthesia. Instrumentation of the airway with either a cuffed endotracheal tube or laryngeal mask airway is acceptable and should be performed by the most experienced staff available.
Despite the long list of precautions suggested by our institutional guidelines, it is difficult to list details of all the modifications to practice that have occurred. Questions concerning best practice remain. For example: should the pager be clipped on the OR uniform inside the OR? Should we use tape from the roll to secure the endotracheal tube or should the tape be precut? Anesthesiologists are familiar with the importance of vigilance in maintaining patient safety. A similar high level of vigilance is necessary to prevent the spread of this serious infection.
Emergency tracheal intubation of SARS patients outside the OR (Appendix III)
In the second month of the outbreak, a cluster of six health care workers contracted SARS after participating in a difficult and prolonged tracheal intubation.
hood, gown, gloves etc., as outlined in the previous section. There must be a well-rehearsed plan and protective clothing, intubating equipment and essential drugs must be provided. Particular care is necessary for the removal of potentially contaminated clothing.
In summary, it is extraordinary that the spread of the infection in the GTA outbreak can be traced to one person with unrecognized SARS. The outbreak disrupted the health care and living in a city the size of Toronto. One hopes for greater vigilance in the future. Anesthesiologists are unique in their frequent exposure to respiratory secretions and blood. We must pay greater heed of our environment to protect ourselves, our patients and our families from infectious disease. A AP PP PE EN ND DI IX X I I Routine precautions for non-severe acute respiratory syndrome patients in the operating room (OR) 1 1. . D Dr re es ss s --R Ro ou ut ti in ne e P Pr re ec ca au ut ti io on ns s -For all patient contact in the OR and postanesthesia care unit, anesthesia staff should wear gloves, and surgical facemasks.
-For tracheal intubation, extubation and all other maneuvers involving the airway, goggles or a face shield should be worn. Gloves should be removed after intubation and before touching anesthesia machines, charts, pens etc. 2 2. . D Di is sp po os sa al l o of f E Eq qu ui ip pm me en nt t -Immediately after intubation has been completed all equipment used during intubation (laryngoscope -blade and handle; airway, lighted stylet, suction catheter, facemask, etc.) should be placed in a container or box.
-In the OR a large container will be placed on the anesthesia machine. The circulating nurse will remove the box and contents, for appropriate cleaning and/or sterilization after intubation is complete. A spare laryngoscope and mask are available in the anesthesia machine drawer. -The anesthesia machine (surface, adjustments knobs etc) will be cleaned between cases but it should be considered dirty. All equipment must be removed from the surfaces of the machine between cases.
-Do not place the anesthesia record, pens, patient charts on the anesthesia machine. If the anesthesia machine or the monitors become visibly contaminated, they should be wiped with a damp virucidal cloth. In our hospital, we use an accelerated hydrogen peroxide cleaner/disinfectant (Virox-5, Virox Technology Inc., Mississauga, ON, Canada). -The transfer route should be discussed with 'Infection Control' team member.
-Patients should wear a facemask (N95 mask).
-Transporters should adopt full droplet /contact precautions (see below).
-Assistance (respiratory therapist) should be provided for the anesthesiologist.
-Staff should wear clean surgical scrub suits laundered by the hospital.
-Minimize the number of individual staff members present. There should be no exchange of staff for the duration of the case.
-Communicate with all level of staff involved in the care of the patient regarding the patient's SARS status.
-Clear the room of unnecessary or over stocked equipment.
-Post "SARS Patient" signs on the OR doors to minimize traffic. Keep doors closed.
-Wash hands (before and after patient care).
B. On entering the OR
Full droplet/contact precaution should be practiced and movement in and out of the OR must be kept to a minimum during the procedure.
-Gown (double gown for high risk procedure).
-Double glove. Remove and dispose of outer pair after direct patient contact and before touching other areas of the room/ anesthesia machine. Subsequent intervention must be performed with double gloves.
-Use N95 mask or equivalent.
-Use a full-face disposable plastic shield for eye protection.
-Powered air purifying respirator (PAPR). Required for staff member performing laryngoscopy or any other airway intervention (including extubation).
-It is recommended that, where possible, staff stay a minimum of 2 metres from the patient to avoid droplet contamination.
C. At the end of the case
-Remove gloves / gown and decontaminate hands with alcohol hand wash.
-Remove face shield / N95 mask / hair cover and wash hands again -Re-gown, glove, hair cover and mask.
-Transfer directly to the postanesthesia care unit isolation room.
-Remove gown/gloves and mask prior to exiting the isolation room.
-Change surgical scrub suit immediately or as soon as practically possible. 2 2. . A An ne es st th he es si ia a m ma ac ch hi in ne e A. Filters -Correct use of a high efficiency, low volume hydrophobic filter provides bacterial/ viral removal greater than 99.999%.
B. Circuits
-Use disposable circle circuit.
-A high efficiency viral filter should be placed on the inspiratory and expiratory limbs of the circuit.
C. Soda lime
-The soda lime does not need to be changed. The end-tidal CO 2 sample line and trap must be changed after the case.
D. Machine /surfaces
-Place the anesthesia machine as far from the patient as practically possible.
-Place contaminated airway equipment in the plastic box for removal from the OR after intubation. Discard needles and syringes immediately after use. 
B. Choice of anesthesia
Tailor to the patient's needs. No special directives.
C. Monitoring
-Use axillary temperature probe. Avoid nasal or esophageal probe. 4 4. . C Cl le ea an ni in ng g a an ne es st th he es si ia a e eq qu ui ip pm me en nt t -Touched parts of the anesthesia machine/monitors will be wiped from time to time with a damp virucidal wipe.
-An attendant, at the conclusion of the proce-dure, will wipe down the anesthesia machine, other than the LCD screen.
-The anesthesiologist, or respiratory technician, is asked to wipe the monitor screen surface if visibly or knowingly contaminated, with a damp virucidal wipe, taking care that the cleaning solution does not drip on the screen. 5 5. . L La ab bo or ra at to or ry y s sp pe ec ci im me en ns s -Indicate the following on the laboratory requisition form: "SARS SPECIAL INVESTIGATION", date of onset of illness, 'travel history' and/or 'contact of known case'.
-Communicate with laboratories FIRST before sending samples.
-Do not send specimens in the pneumatic tube. Send in Biohazard bags, in biohazard screw top bottles and have hand delivered to the laboratory. -Syringes and needles: 1 x 20 mL, 3 x 10 mL, and 3 x 5 mL 3 3. . P Pr ro oc ce ed du ur re e a. After hand-washing, both laryngoscopist and respiratory technician will put on double gloves, gowns, goggles, N95 masks and PAPR hoods in the anteroom, or outside the patient's room.
b. Intubation will be performed in patients who are sedated (midazolam) and paralyzed (succinylcholine or rocuronium). After intubation intermittent positive pressure ventilation will be facilitated with rocuronium.
c. After intubation, the gowns, hoods, and outer gloves will be removed in the anteroom or inside the patient's room. First, the laryngoscopist will be assisted by the respiratory technician whose equipment will then be removed.
d. The patient is returned to the on-going care of the referring physician.
